Lummy Profile

Chongqing Lummy Pharmaceutical Co., Ltd. is a high-tech pharmaceutical enterprise involving pharmaceutical Research and Development, manufacture and sales, which was established in 1999, Chongqing. LUMMY went public on Shenzhen GEM Stock market (Code:300006) in October, 2009. The company total assets are 2.194 billion Yuan, and the registered capital is 202 million Yuan. Lummy has six wholly-owned subsidiary and three holding subsidiary, with 2069 employees.

Lummy was honored as “Top Ten High-tech Innovation Enterprise in Chongqing in 2007, with continuously honored in 2008 and 2009. We was honored as “National Innovation(Trial) Enterprise”,“China Pharmaceutical R&D Best Industrial Enterprise”,“Chongqing Innovation Enterprise”“Chongqing Intellectual Property Trial Company”,Company Credit Evaluation AAA Credit enterprises. Lummy Logo was regarded as “Chongqing Well-known Brand”, many product were named “Chongqing High-tech Product”, “Chongqing key-new product”, “Chongqing Well-known Brand Product”, “ Chongqing Well-known Product” , and Lummy was honored as“Chongqing Honest Tax Advanced Enterprise”.

Lummy pay important attention to R&D investment. We regarded R&D as the leader of business, and we have invested millions of billions Yuan into our R&D. We have strong R&D competence, and we have “Chongqing Lummy Pharmaceutical Technology Center”“Lummy-Sichuan University United Lab”R&D platform. We have Chongqing “City Company Technology Center” and jointly set up with American stock company Sagant Pharmaceutical “Chongqing Pharmaceutical Quality Control Engineer Technology R&D Center”.

We have rich experience and specialized R&D team, and have foreign country return Doctor, Master and more than 100 specialized talents. We have complete system at new drug design, select, pre-clinical trial R&D and clinical. With more than 10 years development, Our R&D have founded the self-creative R&D platform such as Lymph tracer, Lymph node targeted chemotherapy and Cancer node targeted chemotherapy nanometer-drug technology, and micrometer, nanometer disperse technology, sterile bulk drug technology, and anti-effective drug and specialized drug presenting new drug platform. We have applied more than 150 patents, with the new drug application among the best group.

Lummy is one of the firstly company which get GMP and GSP certificates. We have production basis at Chongqing Chayuan New District, Changshou Chemical Industrial Park, Hunan Changsha Liuyang, Yiyang and Chengdu Hi-tech District. We have many different kinds of product, and we have all the injection such as big and small volume injection, powder-injection and freeze powder-injection. We are one of the most full injection companies in domestic pharmaceutical R&D, manufacture. We think Quality is our life and we have cGMP management. Our product inner control is higher than National standard. Our product spot check qualification rate are long term keeps with 100%, winning customer’s accept and trust.

Lummy is continuously exploring market. Our wholly-owned subsidiary Chongqing Lummy Drug Company is a professional pharmaceutical sales company. We have sales network in 29 all domestic province and cities, and we have 25 sale office such as Beijing, Shanghai ,Guangzhou, Chengdu,Xinjiang etc. We have reliable customer and sales network all around our country.

Lummy will continuously take the business concept of “Quality is Company’s Life; Innovation is Company’s Motor; Customer is Company’s resources.” and take the company mission of “Realistic Innovation, Care for people, Dedicate into Pharmaceutical, Found Healthy Together” .We will develop our company according with international cGMP and national GMP/GSP, with strong R&D competence, production technology and advanced management, competitive sales team, and much sales market share in first class Pharmaceutical R&D Company, which will create sufficient value for our shareholder and continuously strive for human health.
Sales Networks